CID 52929046
Pa(18:4(6z,9z,12z,15z)/22:6(4z,7z,10z,13z,16z,19z))
Structural Information
- Molecular Formula
- C43H65O8P
- SMILES
- CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)O)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC
- InChI
- InChI=1S/C43H65O8P/c1-3-5-7-9-11-13-15-17-19-20-21-22-24-26-28-30-32-34-36-38-43(45)51-41(40-50-52(46,47)48)39-49-42(44)37-35-33-31-29-27-25-23-18-16-14-12-10-8-6-4-2/h5-8,11-14,17-19,21-23,26-29,32,34,41H,3-4,9-10,15-16,20,24-25,30-31,33,35-40H2,1-2H3,(H2,46,47,48)/b7-5-,8-6-,13-11-,14-12-,19-17-,22-21-,23-18-,28-26-,29-27-,34-32-/t41-/m1/s1
- InChIKey
- LIQXHYZIOTUFEC-JSXMSGLJSA-N
- Compound name
- [(2R)-1-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-phosphonooxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 741.44898 | 269.8 |
[M+Na]+ | 763.43092 | 275.7 |
[M-H]- | 739.43442 | 264.9 |
[M+NH4]+ | 758.47552 | 277.0 |
[M+K]+ | 779.40486 | 275.7 |
[M+H-H2O]+ | 723.43896 | 260.3 |
[M+HCOO]- | 785.43990 | 277.3 |
[M+CH3COO]- | 799.45555 | 277.1 |
[M+Na-2H]- | 761.41637 | 251.6 |
[M]+ | 740.44115 | 266.7 |
[M]- | 740.44225 | 266.7 |
Literature stripe
Patent stripe
No patent data available for this compound.